Vimseltinib (DCC-3014) is a highly selective, orally active inhibitor of colony-stimulating factor-1 receptor (CSF-IR) and c-Kit with IC50 values of <0.01 µM and 0.1-1 µM, respectively.Vimseltinib is used in studies related to tenosynovial giant cell tumors (TGCT).
Molecular Weight:
431.49
Purity:
>99%
CAS Number:
[1628606-05-2]
Formula:
C23H25N7O2
Target:
CSF-1R (c-Fms)
* VAT and and shipping costs not included. Errors and price changes excepted
